Kirby John J.
SEC insider (Form 3/4/5 filer). CIK 0001556327. Interim CFO at Verrica Pharmaceuticals Inc. (VRCA). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WEST CHESTER, PA.
Companies Kirby John J. has filed insider reports for
- Verrica Pharmaceuticals Inc. (VRCA): Officer, Interim CFO
Kirby John J.
CIK: 0001556327
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRCA
Verrica Pharmaceuticals Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 18, 2026VRCA
Verrica Pharmaceuticals Inc.
PurchaseDirect5K shares at avg. $4.93$25K - Dec 23, 2025VRCA
Verrica Pharmaceuticals Inc.
AwardDirect10K shares- - Nov 25, 2025VRCA
Verrica Pharmaceuticals Inc.
PurchaseDirect3.5K shares at avg. $4.24$15K - Nov 6, 2024VRCA
Verrica Pharmaceuticals Inc.
AwardDirect54.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | VRCA Verrica Pharmaceuticals Inc. | Purchase | 5,000 | $4.93 | $24,650 | Direct |
| Dec 23, 2025 | VRCA Verrica Pharmaceuticals Inc. | Award | 10,000 | - | - | Direct |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc. | Purchase | 3,536 | $4.24 | $15,001 | Direct |
| Nov 6, 2024 | VRCA Verrica Pharmaceuticals Inc. | Award | 54,267 | - | $0 | Direct |
1-4 of 4 transactions